| abstract |
The present invention relates to a benzylphenyl glucopyranoside derivative having an excellent inhibitory effect on the activity of human SGLT1 and / or SGLT2, specifically to a compound or a pharmacologically acceptable salt thereof represented by the following general formula (I) where R represents a hydrogen atom, an amino group, a hydroxyC-alkyl group, etc. d .; R represents a hydrogen atom, etc .; R represents a C-C 1-6 alkyl group, a hydroxy C 1-6 alkyl group, etc .; R represents a hydrogen atom, a C-Sacyl group, etc .; R, R, R and R are the same or different and each represents a hydrogen atom or a C-C1-6 alkyl group, provided that R, R, R and R are not simultaneously hydrogen atoms; n is 0-4; and X represents CH or N. |